Renaissance Capital logo

APGE News

Here's what the top-performing IPOs of 2023 tell us about 2024

Apogee Therapeutics logo

Biotechs make up half of the top 10 best-...read more

Updated: Renaissance Capital's 3Q 2023 US IPO Market Review

Apogee Therapeutics logo

Large Tech IPOs Stage a Comeback in a Volatile 3Q The third quarter of 2023 produced 30 IPOs that raised a combined $7.8 billion, more than the proceeds raised in the full-year 2022 despite no significant increase in deal count from previous quarters. Chip...read more

Renaissance Capital's July IPO Market Update

Apogee Therapeutics logo

Eleven issuers raised a combined $939 million in July, well below the 10-year average (22 IPOs, $5.1B). Four deals raised $80 million or more, along with the year’s first direct listing (SRFM), and a wave of small issuers, which have largely disappeared ...read more

US IPO Weekly Recap: July IPO market kicks off with sizable biotechs

APGE

Following the Independence Day lull, the July IPO market warmed up with two sizable biotechs, joined by two blank check companies. Surf Air Mobility (SRFM), which was expected to begin trading this past week, delayed its direct listing until later this...read more